NAT-OSELTAMIVIR

natco pharma (canada) inc🇨🇦 Health Canada

Approval Id: 3df43c3ff5432db2
Drug Approval Canada Name: NAT-OSELTAMIVIR
Product Name: NAT-OSELTAMIVIR
Status: Marketed
Status Date: 2020-09-29
Original Market Date: 2020-09-29
Din: 02499894
Drug Class: Human
Dosage Form: Powder For Suspension
Route Of Administration: Oral
Schedule: Prescription
Ahfs: 08:18.28
Atc Original: J05AH02 OSELTAMIVIR
Atc Name: j 05 ah 02
Aig Number: 0139501005
Company Name: natco pharma (canada) inc
Company Address: 2000 Argentia Road, Plaza 1, Suite 200, Mississauga, Ontario, Canada, L5N 1P7

OSELTAMIVIR (OSELTAMIVIR PHOSPHATE)

6 MG / ML

Authorized

Agency

Health Canada

Country

🇨🇦

Approval Date

Jul 4, 2025

Approval ID

3df43c3ff5432db2

Type

Standard